Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

AGM Statement

25 Jun 2020 07:00

RNS Number : 9954Q
Science in Sport PLC
25 June 2020
 

 

 

25 June 2020

 

 

 

SCIENCE IN SPORT PLC

("Company" or "Group")

AGM Statement

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces the following statement from its Chairman, John Clarke, ahead of the Company's Annual General Meeting ("AGM") to be held this morning.

 

"As previously announced, the Company had conducted a number of scenario analyses which modelled the impact of COVID-19 on revenues for the current financial year and into 2021. Trading is currently in line with the base scenario developed as part of our contingency planning. As expected, retail sales in all markets remain adversely affected compared with normal levels. However, we are making very strong progress with our e-commerce business, with our own PhD and SiS platforms performing well, and our Amazon business outperforming. Pricing improvements and supply chain synergies are delivering an improved gross margin. This, together with planned COVID-19 cost cutting measures now implemented, is protecting our strong cash position.

 

"The Company's financial position remains robust given performance in line with our base scenario. The proceeds from the ÂŁ4.5 million placing in April 2020 means the Company has substantial headroom and can exit the current trading environment well placed to deliver on its long-term growth strategy. As a further contingency we put in place an ÂŁ8.0 million invoice financing debt facility, which remains unused.

 

"Despite the continued high degree of uncertainty from the COVID-19 pandemic and associated economic impact, our strategy remains unchanged, focusing on science-led innovation, building brand equity, taking our share of e-commerce business and developing global markets. We are confident that we are well prepared to deliver on this strategy and will provide further details on progress in our half year results announcement on 16 September 2020.

 

"On behalf of the Board, I would like to thank all employees of the Group for their commitment to the Company in the face of the challenges presented by the COVID-19 pandemic. As a result of their dedication and professionalism, we have continued to serve customers throughout the first half of the year without interruption."

 

For further information:

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

LiberumNominated adviser and broker

Bidhi BhomaJames GreenwoodWill Hall

+44 (0) 20 3100 2000

 

Notes to Editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium protein brand targeting gym lifestyle and sports enthusiasts, and SiS, a leading brand among elite athletes and professional sports teams.

The two brands are sold internationally through multiple retail channels, both traditional and online, including major supermarkets and high street chains, specialist sports retailers and e-commerce sites including Amazon and the brands' own websites. They enable the Company to address the full breadth of the performance nutrition market currently estimated at approximately £10 billion worldwide.

PhD is one of the UK's leading protein brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since launch in 2005. The range now comprises powders, bars, flapjacks, drinks and other products including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include endurance athlete Ross Edgley, WBA international champion Jordan Gill, Team GB Olympic sprinter Asha Philip and leading fitness influencer Obi Vincent. The PhD brand is an official partner to the Tough Mudder Challenge and Race Series.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and endurance. SiS is the official sports nutrition supplier to many professional teams and organisations including Team INEOS Cycling, Team Ineos UK (America's Cup Team), British Cycling, Cycling Australia, USA Cycling and USA Triathlon. SiS supplies more than 100 professional football clubs in the UK, Europe and USA, and is an official partner to the Rock 'n' Roll Marathon Series. SiS brand ambassadors include Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSELFMLESSEDM
Date   Source Headline
30th Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSDirectorate Change
11th Aug 20229:00 amRNSPrice Monitoring Extension
25th Jul 20224:45 pmRNSBroker Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSHalf-Year Trading Update
15th Jun 20224:27 pmRNSResult of AGM
9th Jun 20227:00 amRNSBoard Change
12th May 202211:06 amRNSTR-1: Notification of Major Holdings
9th May 20227:00 amRNSNotice of AGM
5th May 202211:32 amRNSTR-1: Notification of Major Holdings
4th May 20227:00 amRNSPartnership With New York Marathon and NYRR
29th Apr 20227:00 amRNSGrant of Options, Adoption of New LTIP and TVR
28th Apr 20227:00 amRNSBreakthrough Sports Science Technology Study
21st Apr 20222:16 pmRNSTR-1: Notification of Major Holdings
8th Apr 20222:34 pmRNSTR-1: Notification of major holdings
8th Apr 20221:47 pmRNSTR-1: Notification of major holdings
29th Mar 20227:39 amRNSFinal Results
17th Mar 20227:00 amRNSInvestor Presentation
15th Mar 20227:00 amRNSDate of Final Results
10th Mar 20227:00 amRNSInvestor Presentation
22nd Feb 202211:27 amRNSTR-1: Notification of Major Holdings
22nd Feb 202211:24 amRNSTR-1: Notification of Major Holdings
24th Jan 20225:49 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSAppointment of Joint Broker
4th Jan 20224:51 pmRNSHolding(s) in Company
7th Oct 20213:12 pmRNSHolding(s) in Company
29th Sep 20217:00 amRNSPartnership with Milwaukee Bucks
15th Sep 20217:00 amRNSInterim Results
9th Sep 20217:00 amRNSInvestor Presentation
2nd Aug 20217:00 amRNSNew PhD Nutrition 'Life' Range
19th Jul 20217:00 amRNSLaunch of new category-leading product range
14th Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20213:44 pmRNSResult of AGM
22nd Jun 20213:10 pmRNSHolding(s) in Company
21st Jun 202110:57 amRNSHolding(s) in Company
20th May 20217:00 amRNSNotice of AGM
19th May 202112:59 pmRNSNotification of Major Holdings
10th May 20215:10 pmRNSPDMR Share Purchases
10th May 20217:00 amRNSExtends Partnership with INEOS Grenadiers
28th Apr 202111:01 amRNSPDMR Share Purchases
18th Mar 20212:34 pmRNSNotification of Major Holdings
17th Mar 20217:00 amRNSFinal Results
11th Mar 20217:00 amRNSInvestor Presentation
5th Feb 202112:50 pmRNSNotification of Major Holdings
1st Feb 20211:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSCapital Markets Day
15th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.